Oligonucleotide Synthesis Market Worth $16.7 Billion By 2027 –
“Some leading players in the oligonucleotide synthesis market are Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US) and Agilent Technologies. Inc (United States).”
Danaher Corporation (US) opened IDT China, an official business unit, to better serve its regional customer base, reach new customers and provide easier access to its full portfolio of industry-leading products.
Oligonucleotide Synthesis Market is projected to reach $16.7 billion by 2027 from $7.7 billion in 2022, at a CAGR of 16.8% over the forecast period, according to a new report by MarketsandMarkets™. One of the key factors driving market growth is the emerging field of personalized genome sequencing, which helps determine the best approach to patient care, whether preventive, diagnostic or therapeutic. The incorporation of synthesized oligonucleotides to treat various diseases also supports the market growth.
Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350
Browse Detailed TOC on Oligonucleotide Synthesis Market
50 – Numbers
Probes accounted for the second largest segment of the synthesized oligos product segment in 2021.
Probes are an important sub-segment in the synthesized oligonucleotides market. The segment had the second largest market share due to its important applications in the detection of specific nucleic acid sequences and changes occurring therein. Oligos are used as probes in microarrays, in situ hybridization, antisense analysis, and drug carriers.
Hospitals accounted for the largest share of the end-user segment in the oligonucleotide synthesis market in 2021
By end users, hospitals accounted for the largest share of the oligonucleotide synthesis market in 2021. The growth in this market is largely driven by the significant number of inpatient and outpatient visits to hospitals…